998 related articles for article (PubMed ID: 31963507)
1. Glioblastoma Exhibits Inter-Individual Heterogeneity of TSPO and LAT1 Expression in Neoplastic and Parenchymal Cells.
Cai L; Kirchleitner SV; Zhao D; Li M; Tonn JC; Glass R; Kälin RE
Int J Mol Sci; 2020 Jan; 21(2):. PubMed ID: 31963507
[TBL] [Abstract][Full Text] [Related]
2. TSPO-PET and diffusion-weighted MRI for imaging a mouse model of infiltrative human glioma.
Pigeon H; Pérès EA; Truillet C; Jego B; Boumezbeur F; Caillé F; Zinnhardt B; Jacobs AH; Le Bihan D; Winkeler A
Neuro Oncol; 2019 Jun; 21(6):755-764. PubMed ID: 30721979
[TBL] [Abstract][Full Text] [Related]
3. miR-504 suppresses mesenchymal phenotype of glioblastoma by directly targeting the FZD7-mediated Wnt-β-catenin pathway.
Liu Q; Guan Y; Li Z; Wang Y; Liu Y; Cui R; Wang Y
J Exp Clin Cancer Res; 2019 Aug; 38(1):358. PubMed ID: 31419987
[TBL] [Abstract][Full Text] [Related]
4. The role of LAT1 in (18)F-DOPA uptake in malignant gliomas.
Youland RS; Kitange GJ; Peterson TE; Pafundi DH; Ramiscal JA; Pokorny JL; Giannini C; Laack NN; Parney IF; Lowe VJ; Brinkmann DH; Sarkaria JN
J Neurooncol; 2013 Jan; 111(1):11-8. PubMed ID: 23086431
[TBL] [Abstract][Full Text] [Related]
5. NAMPT: A potential prognostic and therapeutic biomarker in patients with glioblastoma.
Guo Q; Han N; Shi L; Yang L; Zhang X; Zhou Y; Yu S; Zhang M
Oncol Rep; 2019 Sep; 42(3):963-972. PubMed ID: 31322259
[TBL] [Abstract][Full Text] [Related]
6. TSPO Imaging in Glioblastoma Multiforme: A Direct Comparison Between 123I-CLINDE SPECT, 18F-FET PET, and Gadolinium-Enhanced MR Imaging.
Jensen P; Feng L; Law I; Svarer C; Knudsen GM; Mikkelsen JD; de Nijs R; Larsen VA; Dyssegaard A; Thomsen G; Fischer W; Guilloteau D; Pinborg LH
J Nucl Med; 2015 Sep; 56(9):1386-90. PubMed ID: 26182972
[TBL] [Abstract][Full Text] [Related]
7. REST-DRD2 mechanism impacts glioblastoma stem cell-mediated tumorigenesis.
Marisetty AL; Lu L; Veo BL; Liu B; Coarfa C; Kamal MM; Kassem DH; Irshad K; Lu Y; Gumin J; Henry V; Paulucci-Holthauzen A; Rao G; Baladandayuthapani V; Lang FF; Fuller GN; Majumder S
Neuro Oncol; 2019 Jun; 21(6):775-785. PubMed ID: 30953587
[TBL] [Abstract][Full Text] [Related]
8. TSPO PET signal using [
Quach S; Holzgreve A; Kaiser L; Unterrainer M; Dekorsy FJ; Nelwan DV; Bartos LM; Kirchleitner SV; Weller J; Weidner L; Niyazi M; Ruf VC; Herms J; Stöcklein S; Wetzel C; Riemenschneider MJ; V Baumgarten L; Thon N; Brendel M; Rupprecht R; Bartenstein P; Tonn JC; Albert NL
Eur J Nucl Med Mol Imaging; 2023 Feb; 50(3):859-869. PubMed ID: 36329288
[TBL] [Abstract][Full Text] [Related]
9. New fluoroethyl phenylalanine analogues as potential LAT1-targeting PET tracers for glioblastoma.
Verhoeven J; Hulpia F; Kersemans K; Bolcaen J; De Lombaerde S; Goeman J; Descamps B; Hallaert G; Van den Broecke C; Deblaere K; Vanhove C; Van der Eycken J; Van Calenbergh S; Goethals I; De Vos F
Sci Rep; 2019 Feb; 9(1):2878. PubMed ID: 30814660
[TBL] [Abstract][Full Text] [Related]
10. System L amino acid transporter LAT1 accumulates O-(2-fluoroethyl)-L-tyrosine (FET).
Habermeier A; Graf J; Sandhöfer BF; Boissel JP; Roesch F; Closs EI
Amino Acids; 2015 Feb; 47(2):335-44. PubMed ID: 25385314
[TBL] [Abstract][Full Text] [Related]
11. New insights for precision treatment of glioblastoma from analysis of single-cell lncRNA expression.
Meng Q; Zhang Y; Li G; Li Y; Xie H; Chen X
J Cancer Res Clin Oncol; 2021 Jul; 147(7):1881-1895. PubMed ID: 33693962
[TBL] [Abstract][Full Text] [Related]
12. Epithelial membrane protein 1 promotes glioblastoma progression through the PI3K/AKT/mTOR signaling pathway.
Miao L; Jiang Z; Wang J; Yang N; Qi Q; Zhou W; Feng Z; Li W; Zhang Q; Huang B; Chen A; Zhang D; Zhao P; Li X
Oncol Rep; 2019 Aug; 42(2):605-614. PubMed ID: 31233190
[TBL] [Abstract][Full Text] [Related]
13. Large Amino Acid Transporter 1 Selective Liposomes of l-DOPA Functionalized Amphiphile for Combating Glioblastoma.
Bhunia S; Vangala V; Bhattacharya D; Ravuri HG; Kuncha M; Chakravarty S; Sistla R; Chaudhuri A
Mol Pharm; 2017 Nov; 14(11):3834-3847. PubMed ID: 28958145
[TBL] [Abstract][Full Text] [Related]
14. Combined expressional analysis, bioinformatics and targeted proteomics identify new potential therapeutic targets in glioblastoma stem cells.
Stangeland B; Mughal AA; Grieg Z; Sandberg CJ; Joel M; Nygård S; Meling T; Murrell W; Vik Mo EO; Langmoen IA
Oncotarget; 2015 Sep; 6(28):26192-215. PubMed ID: 26295306
[TBL] [Abstract][Full Text] [Related]
15. Reducing VDAC1 expression induces a non-apoptotic role for pro-apoptotic proteins in cancer cell differentiation.
Arif T; Krelin Y; Shoshan-Barmatz V
Biochim Biophys Acta; 2016 Aug; 1857(8):1228-1242. PubMed ID: 27080741
[TBL] [Abstract][Full Text] [Related]
16. Imaging temozolomide-induced changes in the myeloid glioma microenvironment.
Foray C; Valtorta S; Barca C; Winkeler A; Roll W; Müther M; Wagner S; Gardner ML; Hermann S; Schäfers M; Grauer OM; Moresco RM; Zinnhardt B; Jacobs AH
Theranostics; 2021; 11(5):2020-2033. PubMed ID: 33500706
[No Abstract] [Full Text] [Related]
17. The TNF receptor family member Fn14 is highly expressed in recurrent glioblastoma and in GBM patient-derived xenografts with acquired temozolomide resistance.
Hersh DS; Harder BG; Roos A; Peng S; Heath JE; Legesse T; Kim AJ; Woodworth GF; Tran NL; Winkles JA
Neuro Oncol; 2018 Sep; 20(10):1321-1330. PubMed ID: 29897522
[TBL] [Abstract][Full Text] [Related]
18. ZWINT: A potential therapeutic biomarker in patients with glioblastoma correlates with cell proliferation and invasion.
Yang L; Han N; Zhang X; Zhou Y; Chen R; Zhang M
Oncol Rep; 2020 Jun; 43(6):1831-1844. PubMed ID: 32323832
[TBL] [Abstract][Full Text] [Related]
19.
Liesche F; Lukas M; Preibisch C; Shi K; Schlegel J; Meyer B; Schwaiger M; Zimmer C; Förster S; Gempt J; Pyka T
Eur J Nucl Med Mol Imaging; 2019 Sep; 46(10):2163-2168. PubMed ID: 31289907
[TBL] [Abstract][Full Text] [Related]
20. Translocator protein (18kDA) (TSPO) marks mesenchymal glioblastoma cell populations characterized by elevated numbers of tumor-associated macrophages.
Weidner L; Lorenz J; Quach S; Braun FK; Rothhammer-Hampl T; Ammer LM; Vollmann-Zwerenz A; Bartos LM; Dekorsy FJ; Holzgreve A; Kirchleitner SV; Thon N; Greve T; Ruf V; Herms J; Bader S; Milenkovic VM; von Baumgarten L; Menevse AN; Hussein A; Sax J; Wetzel CH; Rupprecht R; Proescholdt M; Schmidt NO; Beckhove P; Hau P; Tonn JC; Bartenstein P; Brendel M; Albert NL; Riemenschneider MJ
Acta Neuropathol Commun; 2023 Sep; 11(1):147. PubMed ID: 37697350
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
